EIR Woodfield Pharmaceutical Jan 2012

Stephen Brown FDA$595.00 - Available Now

FDA investigators audited the Woodfield Pharmaceutical - Houston, TX, United States facility and issued inspectional observation (via FDA 483) on 12 Jan 2012.

Product details

  • Category:
  • Inspection end: 12 Jan 2012
  • Location: Houston, United States
  • FEI: 1628196
Add To Cart